ID   RING2_HUMAN             Reviewed;         336 AA.
AC   Q99496; B2RBS7; B3KRH1; Q5TEN1; Q5TEN2;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=E3 ubiquitin-protein ligase RING2;
DE            EC=2.3.2.27;
DE   AltName: Full=Huntingtin-interacting protein 2-interacting protein 3;
DE            Short=HIP2-interacting protein 3;
DE   AltName: Full=Protein DinG;
DE   AltName: Full=RING finger protein 1B;
DE            Short=RING1b;
DE   AltName: Full=RING finger protein 2;
DE   AltName: Full=RING finger protein BAP-1;
DE   AltName: Full=RING-type E3 ubiquitin transferase RING2 {ECO:0000305};
GN   Name=RNF2; Synonyms=BAP1, DING, HIPI3, RING1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Dyer M.J.S., Abdul-Rauf M., Heward J.M., Cui X., Cleary M.L.,
RA   Catovsky D.;
RT   "Interactions of BCL7A with novel ring finger proteins.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li S.-F.;
RT   "Identification of Bap-1, a protein that binds to integrin and is
RT   involved in integrin-mediated signal transduction.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH HIP2, FUNCTION, AND MUTAGENESIS OF CYS-51; CYS-54 AND
RP   HIS-69.
RX   PubMed=11513855; DOI=10.1016/S0014-5793(01)02689-8;
RA   Lee S.-J., Choi J.-Y., Sung Y.-M., Park H., Rhim H., Kang S.;
RT   "E3 ligase activity of RING finger proteins that interact with Hip-2,
RT   a human ubiquitin-conjugating enzyme.";
RL   FEBS Lett. 503:61-64(2001).
RN   [8]
RP   INTERACTION WITH TFCP2.
RX   PubMed=11865070; DOI=10.1128/MCB.22.6.1936-1946.2002;
RA   Tuckfield A., Clouston D.R., Wilanowski T.M., Zhao L.-L.,
RA   Cunningham J.M., Jane S.M.;
RT   "Binding of the RING polycomb proteins to specific target genes in
RT   complex with the grainyhead-like family of developmental transcription
RT   factors.";
RL   Mol. Cell. Biol. 22:1936-1946(2002).
RN   [9]
RP   IDENTIFICATION IN A PRC1-LIKE HPRC-H COMPLEX.
RX   PubMed=12167701; DOI=10.1128/MCB.22.17.6070-6078.2002;
RA   Levine S.S., Weiss A., Erdjument-Bromage H., Shao Z., Tempst P.,
RA   Kingston R.E.;
RT   "The core of the polycomb repressive complex is compositionally and
RT   functionally conserved in flies and humans.";
RL   Mol. Cell. Biol. 22:6070-6078(2002).
RN   [10]
RP   IDENTIFICATION IN COMPLEX WITH E2F6; TFDP1; MAX; MGA; EUHMTASE1; BAT8;
RP   CBX3; RNF1; MBLR; L3MBTL2 AND YAF2.
RX   PubMed=12004135; DOI=10.1126/science.1069861;
RA   Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., Nakatani Y.;
RT   "A complex with chromatin modifiers that occupies E2F- and Myc-
RT   responsive genes in G0 cells.";
RL   Science 296:1132-1136(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A PRC1-LIKE
RP   COMPLEX WITH RING1; PHC2 AND BMI1, FUNCTION, ENZYME ACTIVITY, AND
RP   MUTAGENESIS OF HIS-69 AND ARG-70.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P.,
RA   Jones R.S., Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [12]
RP   IDENTIFICATION IN THE MLL1/MLL COMPLEX.
RX   PubMed=15960975; DOI=10.1016/j.cell.2005.04.031;
RA   Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J.,
RA   Allis C.D., Chait B.T., Hess J.L., Roeder R.G.;
RT   "Physical association and coordinate function of the H3 K4
RT   methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.";
RL   Cell 121:873-885(2005).
RN   [13]
RP   FUNCTION.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene
RT   silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [14]
RP   INTERACTION WITH RYBP; PCGF1; BCOR AND RING1.
RX   PubMed=16943429; DOI=10.1128/MCB.00630-06;
RA   Gearhart M.D., Corcoran C.M., Wamstad J.A., Bardwell V.J.;
RT   "Polycomb group and SCF ubiquitin ligases are found in a novel BCOR
RT   complex that is recruited to BCL6 targets.";
RL   Mol. Cell. Biol. 26:6880-6889(2006).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   IDENTIFICATION IN A PRC1-LIKE COMPLEX, AND INTERACTION WITH PCGF2.
RX   PubMed=19636380; DOI=10.1371/journal.pone.0006380;
RA   Maertens G.N., El Messaoudi-Aubert S., Racek T., Stock J.K.,
RA   Nicholls J., Rodriguez-Niedenfuhr M., Gil J., Peters G.;
RT   "Several distinct polycomb complexes regulate and co-localize on the
RT   INK4a tumor suppressor locus.";
RL   PLoS ONE 4:E6380-E6380(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION IN A PRC1-LIKE COMPLEX, INTERACTION WITH CBX4; CBX6;
RP   CBX7 AND CBX8, AND SUBCELLULAR LOCATION.
RX   PubMed=21282530; DOI=10.1074/mcp.M110.002642;
RA   Vandamme J., Volkel P., Rosnoblet C., Le Faou P., Angrand P.O.;
RT   "Interaction proteomics analysis of polycomb proteins defines distinct
RT   PRC1 Complexes in mammalian cells.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND SER-168, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH PCGF1.
RX   PubMed=26687479; DOI=10.1038/srep18388;
RA   Oliviero G., Munawar N., Watson A., Streubel G., Manning G.,
RA   Bardwell V., Bracken A.P., Cagney G.;
RT   "The variant Polycomb Repressor Complex 1 component PCGF1 interacts
RT   with a pluripotency sub-network that includes DPPA4, a regulator of
RT   embryogenesis.";
RL   Sci. Rep. 5:18388-18388(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 15-114 IN COMPLEX WITH BMI1
RP   AND ZINC IONS, FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBUNIT.
RX   PubMed=16714294; DOI=10.1074/jbc.M602461200;
RA   Li Z., Cao R., Wang M., Myers M.P., Zhang Y., Xu R.M.;
RT   "Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase
RT   complex.";
RL   J. Biol. Chem. 281:20643-20649(2006).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 220-330, INTERACTION WITH
RP   CBX7, AND MUTAGENESIS OF TYR-262.
RX   PubMed=19791798; DOI=10.1021/bi901131u;
RA   Bezsonova I., Walker J.R., Bacik J.P., Duan S., Dhe-Paganon S.,
RA   Arrowsmith C.H.;
RT   "Ring1B contains a ubiquitin-like docking module for interaction with
RT   Cbx proteins.";
RL   Biochemistry 48:10542-10548(2009).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 223-333 IN COMPLEXES WITH
RP   CBX7 AND RYBP, FUNCTION, AND MUTAGENESIS OF TYR-247; HIS-258 AND
RP   TYR-262.
RX   PubMed=20696397; DOI=10.1016/j.str.2010.04.013;
RA   Wang R., Taylor A.B., Leal B.Z., Chadwell L.V., Ilangovan U.,
RA   Robinson A.K., Schirf V., Hart P.J., Lafer E.M., Demeler B.,
RA   Hinck A.P., McEwen D.G., Kim C.A.;
RT   "Polycomb group targeting through different binding partners of RING1B
RT   C-terminal domain.";
RL   Structure 18:966-975(2010).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates
CC       monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub),
CC       thereby playing a central role in histone code and gene
CC       regulation. H2AK119Ub gives a specific tag for epigenetic
CC       transcriptional repression and participates in X chromosome
CC       inactivation of female mammals. May be involved in the initiation
CC       of both imprinted and random X inactivation. Essential component
CC       of a Polycomb group (PcG) multiprotein PRC1-like complex, a
CC       complex class required to maintain the transcriptionally
CC       repressive state of many genes, including Hox genes, throughout
CC       development. PcG PRC1 complex acts via chromatin remodeling and
CC       modification of histones, rendering chromatin heritably changed in
CC       its expressibility. E3 ubiquitin-protein ligase activity is
CC       enhanced by BMI1/PCGF4. Acts as the main E3 ubiquitin ligase on
CC       histone H2A of the PRC1 complex, while RING1 may rather act as a
CC       modulator of RNF2/RING2 activity. In resting B- and T-lymphocytes,
CC       interaction with AURKB leads to block its activity, thereby
CC       maintaining transcription in resting lymphocytes.
CC       {ECO:0000269|PubMed:11513855, ECO:0000269|PubMed:15386022,
CC       ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16714294,
CC       ECO:0000269|PubMed:20696397}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CBX2 and PHC1. Interacts with CHTOP.
CC       Interacts with AURKB (By similarity). Part of the E2F6.com-1
CC       complex in G0 phase composed of E2F6, MGA, MAX, TFDP1, CBX3, BAT8,
CC       EUHMTASE1, RNF1/RING1, RNF2/RING2, MBLR, L3MBTL2 and YAF2.
CC       Component of a PRC1-like complex. Component of some MLL1/MLL
CC       complex, at least composed of the core components KMT2A/MLL1,
CC       ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative
CC       components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX,
CC       MCRS1, MGA, MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A,
CC       RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10.
CC       Interacts with RYBP, HIP2 and TFCP2. Association to the
CC       chromosomal DNA is cell-cycle dependent. Component of repressive
CC       BCOR complex containing Polycomb group subcomplex at least
CC       composed of RYBP, PCGF1, BCOR and RING1. Component of chromatin-
CC       associated Polycomb (PcG) complexes. Interacts with RYBP, PCGF2,
CC       CBX4, CBX6, CBX7 and CBX8. Interacts with RNF1/RING1, BMI1 and
CC       PHC2. Interacts with PCGF1 (PubMed:26687479).
CC       {ECO:0000250|UniProtKB:Q9CQJ4, ECO:0000269|PubMed:11513855,
CC       ECO:0000269|PubMed:11865070, ECO:0000269|PubMed:12004135,
CC       ECO:0000269|PubMed:12167701, ECO:0000269|PubMed:15386022,
CC       ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:16714294,
CC       ECO:0000269|PubMed:16943429, ECO:0000269|PubMed:19636380,
CC       ECO:0000269|PubMed:19791798, ECO:0000269|PubMed:21282530,
CC       ECO:0000269|PubMed:26687479}.
CC   -!- INTERACTION:
CC       P08183:ABCB1; NbExp=2; IntAct=EBI-722416, EBI-1057359;
CC       P35226:BMI1; NbExp=12; IntAct=EBI-722416, EBI-2341576;
CC       O00257:CBX4; NbExp=5; IntAct=EBI-722416, EBI-722425;
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-722416, EBI-4392727;
CC       O95503:CBX6; NbExp=5; IntAct=EBI-722416, EBI-3951758;
CC       O95931:CBX7; NbExp=5; IntAct=EBI-722416, EBI-3923843;
CC       Q9HC52:CBX8; NbExp=9; IntAct=EBI-722416, EBI-712912;
CC       P68400:CSNK2A1; NbExp=3; IntAct=EBI-722416, EBI-347804;
CC       P67870:CSNK2B; NbExp=2; IntAct=EBI-722416, EBI-348169;
CC       Q9H7Z6:KAT8; NbExp=2; IntAct=EBI-722416, EBI-896414;
CC       Q9BSM1:PCGF1; NbExp=13; IntAct=EBI-722416, EBI-749901;
CC       P35227:PCGF2; NbExp=11; IntAct=EBI-722416, EBI-2129767;
CC       Q3KNV8:PCGF3; NbExp=4; IntAct=EBI-722416, EBI-2339807;
CC       Q86SE9:PCGF5; NbExp=4; IntAct=EBI-722416, EBI-2827999;
CC       Q9BYE7:PCGF6; NbExp=4; IntAct=EBI-722416, EBI-1048026;
CC       Q06587:RING1; NbExp=5; IntAct=EBI-722416, EBI-752313;
CC       Q8N488:RYBP; NbExp=6; IntAct=EBI-722416, EBI-752324;
CC       P51668:UBE2D1; NbExp=3; IntAct=EBI-722416, EBI-743540;
CC       P62837:UBE2D2; NbExp=3; IntAct=EBI-722416, EBI-347677;
CC       P61077:UBE2D3; NbExp=3; IntAct=EBI-722416, EBI-348268;
CC       Q9Y2X8:UBE2D4; NbExp=3; IntAct=EBI-722416, EBI-745527;
CC       Q96LR5:UBE2E2; NbExp=3; IntAct=EBI-722416, EBI-2129763;
CC       Q969T4:UBE2E3; NbExp=3; IntAct=EBI-722416, EBI-348496;
CC       P51784:USP11; NbExp=4; IntAct=EBI-722416, EBI-306876;
CC       Q93009:USP7; NbExp=5; IntAct=EBI-722416, EBI-302474;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}.
CC       Chromosome {ECO:0000250}. Note=Enriched on inactive X chromosome
CC       (Xi) in female trophoblast stem (TS) cells as well as
CC       differentiating embryonic stem (ES) cells. The enrichment on Xi is
CC       transient during TS and ES cell differentiation. The association
CC       with Xi is mitotically stable in non-differentiated TS cells (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99496-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99496-2; Sequence=VSP_055439;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Polyubiquitinated in the presence of UBE2D3 (in vitro).
CC       {ECO:0000250}.
CC   -!- PTM: Monoubiquitinated, by auto-ubiquitination. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The hPRC-H complex purification reported by
CC       PubMed:12167701 probably presents a mixture of different PRC1-like
CC       complexes.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI17849.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI17850.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10571; CAA71596.1; -; mRNA.
DR   EMBL; AF141327; AAD29717.1; -; mRNA.
DR   EMBL; AK091574; BAG52383.1; -; mRNA.
DR   EMBL; AK314793; BAG37324.1; -; mRNA.
DR   EMBL; AL109865; CAC00611.1; -; Genomic_DNA.
DR   EMBL; AL109865; CAI17849.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL109865; CAI17850.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471067; EAW91187.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91188.1; -; Genomic_DNA.
DR   EMBL; BC012583; AAH12583.1; -; mRNA.
DR   CCDS; CCDS1365.1; -. [Q99496-1]
DR   RefSeq; NP_009143.1; NM_007212.3. [Q99496-1]
DR   RefSeq; XP_011508153.1; XM_011509851.2. [Q99496-1]
DR   RefSeq; XP_011508154.1; XM_011509852.2. [Q99496-1]
DR   UniGene; Hs.591490; -.
DR   PDB; 2H0D; X-ray; 2.50 A; B=15-114.
DR   PDB; 3GS2; X-ray; 1.70 A; A/C=223-333.
DR   PDB; 3H8H; X-ray; 2.00 A; A=220-330.
DR   PDB; 3IXS; X-ray; 1.70 A; A/C/E/G/I/K=223-333.
DR   PDB; 3RPG; X-ray; 2.65 A; C=1-116.
DR   PDB; 4R8P; X-ray; 3.28 A; L/N=2-116.
DR   PDB; 4S3O; X-ray; 2.00 A; B/E=1-116.
DR   PDBsum; 2H0D; -.
DR   PDBsum; 3GS2; -.
DR   PDBsum; 3H8H; -.
DR   PDBsum; 3IXS; -.
DR   PDBsum; 3RPG; -.
DR   PDBsum; 4R8P; -.
DR   PDBsum; 4S3O; -.
DR   ProteinModelPortal; Q99496; -.
DR   SMR; Q99496; -.
DR   BioGrid; 111972; 720.
DR   DIP; DIP-40034N; -.
DR   IntAct; Q99496; 86.
DR   MINT; MINT-1420125; -.
DR   STRING; 9606.ENSP00000356480; -.
DR   iPTMnet; Q99496; -.
DR   PhosphoSitePlus; Q99496; -.
DR   BioMuta; RNF2; -.
DR   DMDM; 62901044; -.
DR   EPD; Q99496; -.
DR   MaxQB; Q99496; -.
DR   PaxDb; Q99496; -.
DR   PeptideAtlas; Q99496; -.
DR   PRIDE; Q99496; -.
DR   DNASU; 6045; -.
DR   Ensembl; ENST00000367509; ENSP00000356479; ENSG00000121481. [Q99496-2]
DR   Ensembl; ENST00000367510; ENSP00000356480; ENSG00000121481. [Q99496-1]
DR   GeneID; 6045; -.
DR   KEGG; hsa:6045; -.
DR   UCSC; uc001grc.2; human. [Q99496-1]
DR   CTD; 6045; -.
DR   DisGeNET; 6045; -.
DR   GeneCards; RNF2; -.
DR   HGNC; HGNC:10061; RNF2.
DR   HPA; HPA026803; -.
DR   MIM; 608985; gene.
DR   neXtProt; NX_Q99496; -.
DR   OpenTargets; ENSG00000121481; -.
DR   PharmGKB; PA34426; -.
DR   eggNOG; KOG0311; Eukaryota.
DR   eggNOG; ENOG410XQ5G; LUCA.
DR   GeneTree; ENSGT00390000016977; -.
DR   HOGENOM; HOG000273917; -.
DR   HOVERGEN; HBG079942; -.
DR   InParanoid; Q99496; -.
DR   KO; K10695; -.
DR   OMA; PTLMEND; -.
DR   OrthoDB; EOG091G06VO; -.
DR   PhylomeDB; Q99496; -.
DR   TreeFam; TF105501; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; Q99496; -.
DR   GeneWiki; RNF2; -.
DR   GenomeRNAi; 6045; -.
DR   PRO; PR:Q99496; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000121481; -.
DR   CleanEx; HS_BAP1; -.
DR   CleanEx; HS_RNF2; -.
DR   ExpressionAtlas; Q99496; baseline and differential.
DR   Genevisible; Q99496; HS.
DR   GO; GO:0000791; C:euchromatin; IEA:Ensembl.
DR   GO; GO:0071339; C:MLL1 complex; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031519; C:PcG protein complex; IDA:UniProtKB.
DR   GO; GO:0035102; C:PRC1 complex; IDA:UniProtKB.
DR   GO; GO:0001739; C:sex chromatin; IEA:Ensembl.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0071535; F:RING-like zinc finger domain binding; IPI:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
DR   GO; GO:0007281; P:germ cell development; IEA:Ensembl.
DR   GO; GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0036353; P:histone H2A-K119 monoubiquitination; ISS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR032443; RAWUL.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF16207; RAWUL; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome;
KW   Complete proteome; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    336       E3 ubiquitin-protein ligase RING2.
FT                                /FTId=PRO_0000056038.
FT   ZN_FING      51     91       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION        2    179       Interaction with HIP2.
FT                                {ECO:0000269|PubMed:11513855}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     168    168       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    112    112       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:Q9CQJ4}.
FT   VAR_SEQ      84    155       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055439.
FT   MUTAGEN      51     51       C->W: Strong decrease in HIP2-binding;
FT                                when associated with S-54.
FT                                {ECO:0000269|PubMed:11513855}.
FT   MUTAGEN      54     54       C->S: Strong decrease in HIP2-binding;
FT                                when associated with W-51.
FT                                {ECO:0000269|PubMed:11513855}.
FT   MUTAGEN      69     69       H->Y: Loss of HIP2-binding and loss of
FT                                ubiquitin ligase activity on histone H2A.
FT                                {ECO:0000269|PubMed:11513855,
FT                                ECO:0000269|PubMed:15386022}.
FT   MUTAGEN      70     70       R->C: Loss of ubiquitin ligase activity
FT                                on histone H2A.
FT                                {ECO:0000269|PubMed:15386022}.
FT   MUTAGEN     247    247       Y->A: Reduced interaction with CBX7.
FT                                {ECO:0000269|PubMed:20696397}.
FT   MUTAGEN     258    258       H->A: Reduced interaction with CBX7.
FT                                {ECO:0000269|PubMed:20696397}.
FT   MUTAGEN     262    262       Y->A: Reduced interaction with CBX7.
FT                                {ECO:0000269|PubMed:19791798,
FT                                ECO:0000269|PubMed:20696397}.
FT   HELIX        13     16       {ECO:0000244|PDB:4S3O}.
FT   HELIX        21     24       {ECO:0000244|PDB:4S3O}.
FT   STRAND       37     39       {ECO:0000244|PDB:2H0D}.
FT   HELIX        42     45       {ECO:0000244|PDB:4S3O}.
FT   HELIX        46     49       {ECO:0000244|PDB:4S3O}.
FT   TURN         52     54       {ECO:0000244|PDB:4S3O}.
FT   STRAND       55     57       {ECO:0000244|PDB:4R8P}.
FT   STRAND       59     64       {ECO:0000244|PDB:4S3O}.
FT   TURN         65     67       {ECO:0000244|PDB:4S3O}.
FT   STRAND       70     72       {ECO:0000244|PDB:4S3O}.
FT   HELIX        73     80       {ECO:0000244|PDB:4S3O}.
FT   TURN         88     90       {ECO:0000244|PDB:4S3O}.
FT   HELIX        97     99       {ECO:0000244|PDB:4S3O}.
FT   STRAND      100    102       {ECO:0000244|PDB:4S3O}.
FT   HELIX       104    113       {ECO:0000244|PDB:4S3O}.
FT   STRAND      225    232       {ECO:0000244|PDB:3GS2}.
FT   TURN        234    236       {ECO:0000244|PDB:3GS2}.
FT   STRAND      246    251       {ECO:0000244|PDB:3GS2}.
FT   HELIX       256    277       {ECO:0000244|PDB:3GS2}.
FT   HELIX       283    285       {ECO:0000244|PDB:3IXS}.
FT   HELIX       288    290       {ECO:0000244|PDB:3IXS}.
FT   STRAND      291    296       {ECO:0000244|PDB:3GS2}.
FT   STRAND      302    304       {ECO:0000244|PDB:3GS2}.
FT   HELIX       311    318       {ECO:0000244|PDB:3GS2}.
FT   STRAND      321    323       {ECO:0000244|PDB:3GS2}.
FT   STRAND      325    331       {ECO:0000244|PDB:3GS2}.
SQ   SEQUENCE   336 AA;  37655 MW;  90EA546E1F4DB7EC CRC64;
     MSQAVQTNGT QPLSKTWELS LYELQRTPQE AITDGLEIVV SPRSLHSELM CPICLDMLKN
     TMTTKECLHR FCADCIITAL RSGNKECPTC RKKLVSKRSL RPDPNFDALI SKIYPSRDEY
     EAHQERVLAR INKHNNQQAL SHSIEEGLKI QAMNRLQRGK KQQIENGSGA EDNGDSSHCS
     NASTHSNQEA GPSNKRTKTS DDSGLELDNN NAAMAIDPVM DGASEIELVF RPHPTLMEKD
     DSAQTRYIKT SGNATVDHLS KYLAVRLALE ELRSKGESNQ MNLDTASEKQ YTIYIATASG
     QFTVLNGSFS LELVSEKYWK VNKPMELYYA PTKEHK
//
